LEADER 01000naa a22002652 4500
001 NLM311143091
003 DE-627
005 20231225141627.0
007 cr uuu---uuuuu
008 231225s2020 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2020.108509  |2 doi 
028 5 2 |a pubmed24n1037.xml 
035 |a (DE-627)NLM311143091 
035 |a (NLM)32535188 
035 |a (PII)S1521-6616(20)30456-3 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Ciceri, Fabio  |e verfasserin  |4 aut 
245 1 0 |a Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 
264 1 |c 2020 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 21.07.2020 
500 |a Date Revised 10.01.2021 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. 
520 |a BACKGROUND: National health-system hospitals of Lombardy faced a heavy burden of admissions for acute respiratory distress syndromes associated with coronavirus disease (COVID-19). Data on patients of European origin affected by COVID-19 are limited 
520 |a METHODS: All consecutive patients aged ≥18 years, coming from North-East of Milan's province and admitted at San Raffaele Hospital with COVID-19, between February 25th and March 24th, were reported, all patients were followed for at least one month. Clinical and radiological features at admission and predictors of clinical outcomes were evaluated 
520 |a RESULTS: Of the 500 patients admitted to the Emergency Unit, 410 patients were hospitalized and analyzed: median age was 65 (IQR 56-75) years, and the majority of patients were males (72.9%). Median (IQR) days from COVID-19 symptoms onset was 8 (5-11) days. At hospital admission, fever (≥ 37.5 °C) was present in 67.5% of patients. Median oxygen saturation (SpO2) was 93% (range 60-99), with median PaO2/FiO2 ratio, 267 (IQR 184-314). Median Radiographic Assessment of Lung Edema (RALE) score was 9 (IQR 4-16). More than half of the patients (56.3%) had comorbidities, with hypertension, coronary heart disease, diabetes and chronic kidney failure being the most common. The probability of overall survival at day 28 was 66%. Multivariable analysis showed older age, coronary artery disease, cancer, low lymphocyte count and high RALE score as factors independently associated with an increased risk of mortality 
520 |a CONCLUSION: In a large cohort of COVID-19 patients of European origin, main risk factors for mortality were older age, comorbidities, low lymphocyte count and high RALE 
650 4 |a Clinical Trial 
650 4 |a Journal Article 
650 4 |a ARDS 
650 4 |a COVID-19 
650 4 |a Infection 
650 4 |a RALE score 
700 1 |a Castagna, Antonella  |e verfasserin  |4 aut 
700 1 |a Rovere-Querini, Patrizia  |e verfasserin  |4 aut 
700 1 |a De Cobelli, Francesco  |e verfasserin  |4 aut 
700 1 |a Ruggeri, Annalisa  |e verfasserin  |4 aut 
700 1 |a Galli, Laura  |e verfasserin  |4 aut 
700 1 |a Conte, Caterina  |e verfasserin  |4 aut 
700 1 |a De Lorenzo, Rebecca  |e verfasserin  |4 aut 
700 1 |a Poli, Andrea  |e verfasserin  |4 aut 
700 1 |a Ambrosio, Alberto  |e verfasserin  |4 aut 
700 1 |a Signorelli, Carlo  |e verfasserin  |4 aut 
700 1 |a Bossi, Eleonora  |e verfasserin  |4 aut 
700 1 |a Fazio, Maria  |e verfasserin  |4 aut 
700 1 |a Tresoldi, Cristina  |e verfasserin  |4 aut 
700 1 |a Colombo, Sergio  |e verfasserin  |4 aut 
700 1 |a Monti, Giacomo  |e verfasserin  |4 aut 
700 1 |a Fominskiy, Efgeny  |e verfasserin  |4 aut 
700 1 |a Franchini, Stefano  |e verfasserin  |4 aut 
700 1 |a Spessot, Marzia  |e verfasserin  |4 aut 
700 1 |a Martinenghi, Carlo  |e verfasserin  |4 aut 
700 1 |a Carlucci, Michele  |e verfasserin  |4 aut 
700 1 |a Beretta, Luigi  |e verfasserin  |4 aut 
700 1 |a Scandroglio, Anna Maria  |e verfasserin  |4 aut 
700 1 |a Clementi, Massimo  |e verfasserin  |4 aut 
700 1 |a Locatelli, Massimo  |e verfasserin  |4 aut 
700 1 |a Tresoldi, Moreno  |e verfasserin  |4 aut 
700 1 |a Scarpellini, Paolo  |e verfasserin  |4 aut 
700 1 |a Martino, Gianvito  |e verfasserin  |4 aut 
700 1 |a Bosi, Emanuele  |e verfasserin  |4 aut 
700 1 |a Dagna, Lorenzo  |e verfasserin  |4 aut 
700 1 |a Lazzarin, Adriano  |e verfasserin  |4 aut 
700 1 |a Landoni, Giovanni  |e verfasserin  |4 aut 
700 1 |a Zangrillo, Alberto  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 217(2020) vom: 01. Aug., Seite 108509  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:217  |g year:2020  |g day:01  |g month:08  |g pages:108509 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2020.108509  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 217  |j 2020  |b 01  |c 08  |h 108509